LASERSIGHT INC /DE
8-K, 1996-07-09
ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS
Previous: SHIVA CORP, 8-K/A, 1996-07-09
Next: DUFF & PHELPS UTILITIES TAX FREE INCOME INC, N-30D, 1996-07-09



                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549


                                    FORM 8-K


                                 CURRENT REPORT


                     Pursuant to Section 13 or 15(d) of the
                         Securities Exchange Act of 1934


Date of Report (date of earliest event reported):  July 9, 1996 (July 9, 1996)


                             LASERSIGHT INCORPORATED
              Exact name of registrant as specified in its charter


                                    Delaware
                  State or other jurisdiction of incorporation



         0-19671                                         65-0273162
Commission File Number                      I.R.S. Employer Identification No.

                 12161 Lackland Road, St. Louis, Missouri 63146
                     Address of Principal Executive Offices



Registrant's telephone number, including area code:           (314) 469-3220
                                                              --------------



<PAGE>


Item 5.   Other Events.

The  press  release  issued by  LaserSight  Incorporated  dated  July 9, 1996 is
incorporated by reference herein.

Item 7.  Financial Statements, Pro Forma Financial Information and Exhibits.

      (c) Exhibits

      Exhibit 99.  Press Release dated  July 9, 1996



                                   SIGNATURES

Pursuant  to the  requirements  of the  Securities  Exchange  Act of  1934,  the
Registrant  has duly  caused  this  report  to be  signed  on its  behalf by the
undersigned hereunto duly authorized.

                                            LaserSight Incorporated



Date:  July 9, 1996                         By: /s/Gregory L. Wilson
                                                -------------------------
                                                  Gregory L. Wilson
                             Chief Financial Officer
<PAGE>



                                    EXHIBIT 99



                               NASDAQ SYMBOL: LASE

            LASERSIGHT ANNOUNCES PRELIMINARY SECOND-QUARTER ESTIMATES

St.  Louis,  MO --  July  9,  1996.....  LaserSight  Incorporated  (NASDAQ:LASE)
announced today that, based upon preliminary estimates,  second quarter revenues
are expected to increase approximately 30 percent over the first quarter of 1996
to between  $6.0 and $6.2  million  from $4.6  million.  Earnings  per share are
expected to improve from the first quarter of 1996,  with a second quarter range
of an estimated $0.03 loss to break even, versus a $0.19 loss. These preliminary
results  are subject to the Company  closing its books and  customary  quarterly
review procedures by the Company and its independent auditors.

"The second quarter represents a dramatic  improvement over the first quarter in
both bottom line results and positive  impact to the  Company's  balance  sheet.
This  balance  sheet  impact  stems  from  the  more  stringent   credit  policy
implemented in April associated with laser sales during the second quarter. Over
80 percent of the laser sales have either been  collected  or are due within the
next 90 days," said Michael R. Farris,  president and chief executive officer of
LaserSight.

The addition in late May of Mr. Paul  Reithler-Barros as vice president of sales
and marketing for LaserSight  Technologies  contributed to the leadership of the
Company and the  existence  of a sales  backlog at the end of June.  Mr.  Farris
added, "Demand for our technology  internationally remains strong. With progress
in our technology  division and the completion of the  acquisition of the assets
of the Northern New Jersey Eye  Institute,  we are now focused more than ever on
acquiring managed care lives and key ophthalmic practices."

LaserSight  Incorporated is a holding  company with four operating  subsidiaries
engaged  in  the  business  of  laser  manufacturing  and  international  sales,
third-party managed vision care administration,  ophthalmic practice management,
and health and vision care consulting services.

For additional information please contact:               
Marti Benfield, Investor Relations
(314)  469-3220






© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission